XML 37 R24.htm IDEA: XBRL DOCUMENT v3.20.1
Equity-based Compensation and Equity Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2020
Schedule of Restricted Common Stock Activity The following table shows restricted stock activity during the three months ended March 31, 2020:

 

 

 

Restricted stock awards

 

 

 

 

 

 

 

Grant date

 

 

 

Number of

 

 

fair value

 

 

 

shares

 

 

(per share)

 

Unvested at December 31, 2019

 

 

586,929

 

 

$

2.97

 

Granted

 

 

226,335

 

 

 

1.70

 

Vested

 

 

(9,318

)

 

 

13.53

 

Forfeited

 

 

(33,755

)

 

 

2.45

 

Unvested at March 31, 2020

 

 

770,191

 

 

$

2.49

 

 

Schedule of Equity-based Compensation Expenses

The following table summarizes equity‑based compensation expense within the Company’s consolidated statements of operations and comprehensive loss for the three months ended March 31, 2020 and 2019 (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

 

2020

 

 

2019

 

 

Research and development

 

$

441

 

 

$

284

 

 

General and administrative

 

 

654

 

 

 

670

 

 

 

 

$

1,095

 

 

$

954

 

 

Schedule of Equity-based Compensation Expenses by Award Type

The following table summarizes equity‑based compensation expense by type of award for the three months ended March 31, 2020 and 2019 (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

 

2020

 

 

2019

 

 

Stock options

 

$

875

 

 

$

926

 

 

Restricted stock awards

 

 

220

 

 

 

28

 

 

 

 

$

1,095

 

 

$

954

 

 

2015 and 2017 Plan  
Schedule of Stock Option Activity The following table summarizes stock option activity during the three months ended March 31, 2020 under the 2015 Plan and the 2017 Plan.

 

 

 

Stock options outstanding

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

average

 

 

Aggregate

 

 

 

 

 

 

 

average

 

 

remaining

 

 

Intrinsic

 

 

 

Number of

 

 

exercise

 

 

contractual

 

 

value (a)

 

 

 

options

 

 

price

 

 

term (in years)

 

 

(in thousands)

 

Outstanding at December 31, 2019

 

 

2,286,419

 

 

$

9.24

 

 

 

8.7

 

 

$

43

 

Granted

 

 

1,052,113

 

 

 

1.77

 

 

 

 

 

 

 

 

Forfeited

 

 

(86,073

)

 

 

9.30

 

 

 

 

 

 

 

1

 

Outstanding at March 31, 2020

 

 

3,252,459

 

 

 

6.82

 

 

 

8.9

 

 

$

18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested or expected to vest at March 31, 2020

 

 

3,252,459

 

 

 

6.82

 

 

 

8.9

 

 

 

18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at March 31, 2020

 

 

919,285

 

 

 

11.26

 

 

 

8.0

 

 

$

 

 

(a)

The aggregate intrinsic value is calculated as the difference between the exercise price of the options and the fair market value of the underlying common stock for the options that were in the money at March 31, 2020 and December 31, 2019.